申请人:Vanderbilt University
公开号:US20170174689A1
公开(公告)日:2017-06-22
The present invention provides for compounds that inhibit the activity of an anti-apoptotic Bcl-2 family member Myeloid cell leukemia-1 (Mcl-1) protein. The present invention also provides for pharmaceutical compositions as well as methods for using compounds for treatment of diseases and conditions (e.g., cancer) characterized by the over-expression or dysregulation of Mcl-1 protein.
本发明提供了一种抑制抗凋亡Bcl-2家族成员髓性细胞白血病-1(Mcl-1)蛋白活性的化合物。本发明还提供了药物组合物以及使用化合物治疗由于Mcl-1蛋白过度表达或失调而导致的疾病和病况(例如癌症)的方法。